Pittsburgh, PANCT07079826Now EnrollingIRB Ready

Opioid Withdrawal Clinical Trial in Pittsburgh, PA

Access cutting-edge opioid withdrawal treatment through this clinical trial at a research site in Pittsburgh. Study-provided care at no cost to qualified participants.

Sponsored by Payel Roy

Quick Self-Assessment

See if you qualify for this Pittsburgh location

Preparing your pre-screening questions…

Expert Care in Pittsburgh

Access opioid withdrawal specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related opioid withdrawal treatment provided free

Apply for This Pittsburgh Location

Check if you qualify for this opioid withdrawal clinical trial in Pittsburgh, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Pittsburgh

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Pittsburgh site if eligible
  4. 4Begin participation

About This Opioid Withdrawal Study in Pittsburgh

This study is evaluating the Sparrow Link, a wearable device that delivers gentle electrical signals to nerves in the outer ear (a technique known as transcutaneous auricular neurostimulation, or tAN). The goal is to assess whether the device is feasible to use, acceptable to patients, and may help reduce opioid withdrawal symptoms in hospitalized adults being treated for opioid use disorder (OUD). Participants will be randomly assigned to receive either the active device or a sham (inactive) version. Neither participants nor their clinical teams will know which version is used. All participants will continue receiving standard hospital care for opioid withdrawal. Researchers will collect information on how long participants use the device, whether they stop using it early, and changes in withdrawal severity. The study will also examine pain, craving, mood, anxiety, heart rate variability, and opioid use during hospitalization.

Sponsor: Payel Roy

Who Can Participate

Inclusion Criteria

Eligible participants must meet at least ONE of the following criteria:
Are continuing to experience opioid withdrawal symptoms:
Despite Maximal medical therapy with methadone, buprenorphine, full agonist opioids, or non-opioid medications, or
During tapering or detox from full agonist opioids. OR
Have chosen to decline methadone or buprenorphine but still require support for withdrawal symptoms and/or pain management. Additionally, participants must:
Be 18 years old or older.
Have active history of opioid use disorder.
Have a COWS score between 5-24 (Mild-moderate opioid withdrawal), indicating residual withdrawal symptoms.
Be able to provide informed consent.

Exclusion Criteria

History of or active seizure disorder.
Presence of a cardiac device (e.g., pacemaker, defibrillator).
Presence of a neurostimulator (e.g., deep brain stimulator, spinal cord stimulator).
Pregnant or lactating individuals.
COWS score ≥ 25 (Severe Withdrawal), requiring medical stabilization.
Abnormal ear Anatomy, ear Infections, or skin Conditions at Electrode Sites, including congenital malformations, post-surgical changes, significant scarring, open wounds, or hypersensitivity.
Active neurological disorders, such as traumatic brain injury, stroke, multiple sclerosis, or other conditions that may interfere with neurostimulation effects or autonomic regulation as assessed at the investigator's discretion.
Severe alcohol or benzodiazepine withdrawal that is not adequately controlled with medication, per investigator discretion.
Known or documented allergy to hydrocolloid adhesives, as evidenced in the medical record.
Evidence of active psychosis, as documented in the medical record or reported by clinical staff.
Non-English speakers, whose limited English proficiency precludes informed consent or meaningful participation in study assessments validated only in English.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Pittsburgh?

Yes, this clinical trial (NCT07079826) has an active research site in Pittsburgh, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Opioid Withdrawal Treatment Options in Pittsburgh, PA

If you're searching for opioid withdrawal treatment options in Pittsburgh, PA, this clinical trial (NCT07079826) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Pittsburgh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced opioid withdrawal specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all opioid withdrawal clinical trials near you to find additional studies recruiting in your area.

More Huntingtons Disease Trials in Pittsburgh, PA

See all huntingtons disease clinical trials recruiting in Pittsburgh — not just this study.

Browse Huntingtons Disease Trials in Pittsburgh →

Browse More Trials by Condition

Huntingtons Disease TrialsRheumatoid Arthritis TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Pittsburgh?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Pittsburgh, PA